ロード中...
Spironolactone blocks Epstein–Barr virus production by inhibiting EBV SM protein function
Clinically available drugs active against Epstein–Barr virus (EBV) and other human herpesviruses are limited to those targeting viral DNA replication. To identify compounds directed against other steps in the viral life cycle, we searched for drugs active against the EBV SM protein, which is essenti...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822607/ https://ncbi.nlm.nih.gov/pubmed/26976570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1523686113 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|